Qiang Niu, Yu Liu, Yujing Zheng, Ziwei Tang, Yuna Qian, Ruogu Qi, Jianliang Shen, Ping Zhao. Author correction to ‘Co-delivery of nigericin and decitabine using hexahistidine-metal nanocarriers for pyroptosis-induced immunotherapeutics' Acta Pharm Sin B 12 (2022) 4458-4471J. Acta Pharmaceutica Sinica B, 2024, 14(5): 2359-2360. DOI: 10.1016/j.apsb.2024.02.021
|
Citation:
|
Qiang Niu, Yu Liu, Yujing Zheng, Ziwei Tang, Yuna Qian, Ruogu Qi, Jianliang Shen, Ping Zhao. Author correction to ‘Co-delivery of nigericin and decitabine using hexahistidine-metal nanocarriers for pyroptosis-induced immunotherapeutics' Acta Pharm Sin B 12 (2022) 4458-4471J. Acta Pharmaceutica Sinica B, 2024, 14(5): 2359-2360. DOI: 10.1016/j.apsb.2024.02.021
|
Qiang Niu, Yu Liu, Yujing Zheng, Ziwei Tang, Yuna Qian, Ruogu Qi, Jianliang Shen, Ping Zhao. Author correction to ‘Co-delivery of nigericin and decitabine using hexahistidine-metal nanocarriers for pyroptosis-induced immunotherapeutics' Acta Pharm Sin B 12 (2022) 4458-4471J. Acta Pharmaceutica Sinica B, 2024, 14(5): 2359-2360. DOI: 10.1016/j.apsb.2024.02.021
|
Citation:
|
Qiang Niu, Yu Liu, Yujing Zheng, Ziwei Tang, Yuna Qian, Ruogu Qi, Jianliang Shen, Ping Zhao. Author correction to ‘Co-delivery of nigericin and decitabine using hexahistidine-metal nanocarriers for pyroptosis-induced immunotherapeutics' Acta Pharm Sin B 12 (2022) 4458-4471J. Acta Pharmaceutica Sinica B, 2024, 14(5): 2359-2360. DOI: 10.1016/j.apsb.2024.02.021
|